Multicenter Registry for the Optimal Antithrombotic Therapy in the Patients with Arial Fibrillation Undergoing Percutaneous Coronary Intervention Study

Multicenter Registry for the Optimal Antithrombotic Therapy in the Patients with Arial Fibrillation Undergoing Percutaneous Coronary Intervention Study - MILESTONE Study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000015531

Enrollment

100

Registered

2014-10-26

Start date

2014-04-28

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial fibrillation Coronary artery disease

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who have undergone PCI with EES

Exclusion criteria

Exclusion criteria: Patients who have already been implanted other DES Patiens with acute myocardial infarction Patients judged by the treating physician to be unsuitable as study subjects

Design outcomes

Primary

Measure	Time frame
Bleeding events at just after PCI, 30 days and 1 year follow-up	—

Countries

Japan

Contacts

Public ContactHidehira Fukaya

Kitasato University School of Medicine Department of Cardiovascular Medicine

hidehira@med.kitasato-u.ac.jp042-778-8111

Outcome results